Accelerator mass spectrometry in biomedical research
Description
Biological effects occur in natural systems at chemical concentrations of parts per billion (1:109) or less. Affected biomolecules may be separable in only milligram or microgram quantities. Quantification at attomole sensitivity is needed to study these interactions. AMS measures isotope concentrations to parts per 1013--15 on milligram-sized samples and is ideal for quantifying long-lived radioisotopic labels that are commonly used to trace biochemical pathways in natural systems. 14C-AMS has now been coupled to a variety of organic separation and definition technologies. The primary research investigates pharmacokinetics and genotoxicities of toxins and drugs at very low doses. Human subject research using AMS includes nutrition, toxicity and elemental balance studies. 3 H, 41Ca and 26Al are also traced by AMS for fundamental biochemical kinetic research. Expansion of biomedical AMS awaits further development of biochemical and accelerator technologies designed specifically for these applications
Availability note (English)
MF available from INIS under the Report Number; Also available from OSTI as DE94004336; NTIS; US Govt. Printing Office Dep.Files
25033670.pdf
Files
(1.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:4435c158cb2b4b4c85b757f23f078e98
|
1.7 MB | Preview Download |
Additional details
Publishing Information
- Imprint Pagination
- 24 p.
- Report number
- UCRL-JC--113838
Conference
- Title
- 6. international conference on accelerator mass spectrometry.
- Dates
- 17 Sep - 1 Oct 1993.
- Place
- Canberra (Australia).
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 25033670
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- ALUMINIUM 26; BIOCHEMICAL REACTION KINETICS; BIOMEDICAL RADIOGRAPHY; CALCIUM 41; CARBON 14; CHEMOTHERAPY; DOSE-RESPONSE RELATIONSHIPS; DRUGS; MASS SPECTROSCOPY; NUTRITION; SENSITIVITY; TECHNOLOGY ASSESSMENT; TOXICITY; TOXINS; TRACER TECHNIQUES; TRITIUM
- Descriptors DEC
- ALUMINIUM ISOTOPES; ANTIGENS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CALCIUM ISOTOPES; CARBON ISOTOPES; DIAGNOSTIC TECHNIQUES; ELECTRON CAPTURE RADIOISOTOPES; EVEN-EVEN NUCLEI; EVEN-ODD NUCLEI; HYDROGEN ISOTOPES; INTERMEDIATE MASS NUCLEI; ISOTOPE APPLICATIONS; ISOTOPES; KINETICS; LIGHT NUCLEI; MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; RADIOISOTOPES; REACTION KINETICS; SECONDS LIVING RADIOISOTOPES; SPECTROSCOPY; THERAPY; YEARS LIVING RADIOISOTOPES
Optional Information
- Contract/Grant/Project number
- Contract W-7405-ENG-48
- Funding organization
- USDOE, Washington, DC (United States).
- Secondary number(s)
- CONF-930960--4.